Novo's expanding collaboration with Weight Watchers
Novo Nordisk expanded their collaboration with Weight Watchers, offering an introductory price of $299
Novo Nordisk has recently expanded it's collaboration with Weight Watchers:
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy ® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry Collaboration Builds a Seamless NovoCare® Pharmacy Integration, Shared Vision to Enhance Outcomes Through WW’s GLP-1 Companion Support, and a Commitment to Publishing Real-World Evidence WeightWatchers Sets the Standard in Evidence-Based Weight Health, Prescribing Only FDA-Approved Medications NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) - WW International, Inc. (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced an expanded collaboration with Novo Nordisk, which includes increased access to authentic, FDA-approved Wegovy® (semaglutide) injection through WeightWatchers Clinic. As the only holistic platform focused on long-term weight health featuring the No. 1 doctor-recommended weight loss program included in the recently announced
So what do Weight Watchers members get out of this deal? Well access to GLP1s for one, but until July 31st 2025, there's a reduced price for Wegovy – $299.
Let's get into the details of the deal, Weight Watcher's bankruptcy, how long this new price will actually last, and what this new partnership means.
The rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack:
